The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation
Petra Molnár(University of Debrecen), Magdolna Szántó(University of Debrecen)
Cited by 0
Related Papers
No related papers found
Powered by citation graph analysis